Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring of cyclosporine A and metabolites in kidney transplant recipients
2005-004299-19Phase 4Completed
- Sponsor
- University Hospital Ostrava
- Start
- Oct 2005
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cyclosporine in Kidney allograft status (RTx), sponsored by University Hospital Ostrava. Primary endpoints: Importance of lymphocyte LC-MS TDM vs conventional CsA monitoring and Role of metabolite AM4N and other CsA metabolites. Started Oct 2005; status: completed.
02
Drugs
cyclosporine
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on 2005-004299-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004299-19.